- Home
- CRS vs ICLR Comparison
CRS vs ICLR Comparison
Compare CRS & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRS
- ICLR
- Stock Information
- Founded
- CRS 1910
- ICLR 1990
- Country
- CRS United States
- ICLR Ireland
- Employees
- CRS N/A
- ICLR N/A
- Industry
- CRS Steel/Iron Ore
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- CRS Industrials
- ICLR Health Care
- Exchange
- CRS Nasdaq
- ICLR Nasdaq
- Market Cap
- CRS 12.2B
- ICLR 13.7B
- IPO Year
- CRS N/A
- ICLR 1998
- Fundamental
- Price
- CRS $239.89
- ICLR $175.00
- Analyst Decision
- CRS Strong Buy
- ICLR Buy
- Analyst Count
- CRS 2
- ICLR 15
- Target Price
- CRS $302.50
- ICLR $209.93
- AVG Volume (30 Days)
- CRS 822.6K
- ICLR 1.0M
- Earning Date
- CRS 10-23-2025
- ICLR 10-22-2025
- Dividend Yield
- CRS 0.33%
- ICLR N/A
- EPS Growth
- CRS 100.54
- ICLR 13.11
- EPS
- CRS 7.42
- ICLR 9.73
- Revenue
- CRS $2,877,100,000.00
- ICLR $8,089,820,000.00
- Revenue This Year
- CRS $10.39
- ICLR N/A
- Revenue Next Year
- CRS $9.95
- ICLR $1.73
- P/E Ratio
- CRS $32.35
- ICLR $17.98
- Revenue Growth
- CRS 4.25
- ICLR N/A
- 52 Week Low
- CRS $136.05
- ICLR $125.10
- 52 Week High
- CRS $290.84
- ICLR $310.54
- Technical
- Relative Strength Index (RSI)
- CRS 43.05
- ICLR 53.09
- Support Level
- CRS $243.38
- ICLR $164.00
- Resistance Level
- CRS $255.99
- ICLR $180.95
- Average True Range (ATR)
- CRS 6.44
- ICLR 6.38
- MACD
- CRS 1.00
- ICLR -0.99
- Stochastic Oscillator
- CRS 34.76
- ICLR 64.59
About CRS Carpenter Technology Corporation
Carpenter Technology Corp supplies specialty metals to a variety of end markets, including aerospace and defense, industrial machinery and consumer durables, medical, and energy, among others. The company's reportable segments include; Specialty Alloys Operations and Performance Engineered Products. It generates maximum revenue from the Specialty Alloys Operations segment. The SAO segment is comprised of the company's alloy and stainless steel manufacturing operations. This includes operations performed at mills predominantly in Reading and Latrobe, Pennsylvania, and surrounding areas as well as South Carolina and Alabama. Geographically, the company derives its maximum revenue from the United States and the rest from Europe, Asia Pacific, Mexico, Canada, and other regions.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.